Northern Trust’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.26M | Buy |
|
|||||
|
2025
Q2 | $3.65M | Sell |
|
|||||
|
2025
Q1 | $2.96M | Sell |
|
|||||
|
2024
Q4 | $4.69M | Buy |
|
|||||
|
2024
Q3 | $15.5M | Buy |
|
|||||
|
2024
Q2 | $10.8M | Buy |
|
|||||
|
2024
Q1 | $15.6M | Buy |
|
|||||
|
2023
Q4 | $8.62M | Buy |
|
|||||
|
2023
Q3 | $6.79M | Buy |
|
|||||
|
2023
Q2 | $8.18M | Buy |
|
|||||
|
2023
Q1 | $7.57M | Buy |
|
|||||
|
2022
Q4 | $8.39M | Buy |
|
|||||
|
2022
Q3 | $6.13M | Buy |
|
|||||
|
2022
Q2 | $4.16M | Buy |
|
|||||
|
2022
Q1 | $8.08M | Sell |
|
|||||
|
2021
Q4 | $9.02M | Buy |
|
|||||
|
2021
Q3 | $5.92M | Sell |
|
|||||
|
2021
Q2 | $6.58M | Buy |
|
|||||
|
2021
Q1 | $7.87M | Sell |
|
|||||
|
2020
Q4 | $9.54M | Buy |
|
|||||
|
2020
Q3 | $3.21M | Sell |
|
|||||
|
2020
Q2 | $3.29M | Buy |
|